2026-01-16 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS (Biopsy of the Prostate Avoidance Stratification Study), a Phase…
